16th Annual Generics And Patent Strategies London, 13-14 May 2013
Main Category: ConferencesArticle Date: 06 Feb 2013 - 9:00 PST
16th Annual Generics And Patent Strategies London, 13-14 May 2013
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
SMi is pleased to announce the 16th annual Generics and Patent Strategies conference taking place in London from 13-14 May 2013. The conference will see world-renowned experts present the hottest topics and key challenges faced within the Generics industry today in combination with panel discussions, that will provide the latest updates on increasing profitability in a highly competitive market, how to overcome some of the IP issues faced when challenging patents and takes a detailed look at the pricing pressures surrounding an already saturated marketplace.
SMi is delighted to confirm Paul Csiszar, Director, Basic Industries, Manufacturing and Agriculture, European Commission as one of the speakers of the upcoming event.
He will address the essential tools for commercialisation regarding he the recent developments in antitrust enforcement in the pharma sector. He will look closely at the overview of the commission's current enforcement activities, update on the patent settlement monitoring and interaction between regulatory and competition issues.
Delegates will be given a comprehensive overview of different strategies involved in regulatory affairs and how these can work to your advantage in Europe, there will be a discussion on:
- How originator companies are protecting their compounds and how you can strategically navigate around these issues
- How to identify ways to obtain a foothold in the Marketplace over your competitors: are value added Generics or Biosimilars the answer?
- How Patent litigation can work to your advantage when launching a first to market Generic, and to determine the impacts of "Big Pharma" launching Generics into the Marketplace and what this means for smaller Generics companies.
Visit our conferences section for the latest news on this subject.
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit http://www.smi-online.co.uk
MLA
25 May. 2013. <http://www.medicalnewstoday.com/releases/255988.php>
APA
http://www.medicalnewstoday.com/releases/255988.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'16th Annual Generics And Patent Strategies London, 13-14 May 2013'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


